1
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich Syndrome (WAS); X-linked ThrombocytopeniaLast Updated:August 16, 2017Completed
X-linked Thrombocytopenia: 5 Clinical Trials
Hide Studies Not Open or Pending
2
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Condition(s):Wiskott-Aldrich Syndrome; Thrombocytopenia; BleedingLast Updated:March 18, 2019Terminated
3
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:May 6, 2020Recruiting
4
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
Condition(s):Bone Marrow Failure Syndrome; Thalassemia; Sickle Cell Disease; Diamond Blackfan Anemia; Acquired Neutropenia in Newborn; Acquired Anemia Hemolytic; Acquired Thrombocytopenia; Hemophagocytic Lymphohistiocytoses; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; Common Variable Immunodeficiency; X-linked Lymphoproliferative Disease; Severe Combined Immunodeficiency; Hurler Syndrome; Mannosidosis; AdrenoleukodystrophyLast Updated:November 8, 2022Active, not recruiting
5
Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
Condition(s):Wiskott-Aldrich SyndromeLast Updated:December 28, 2020Completed